EnTox Science accelerates life science research and therapeutic discovery with analytical instrumentation for in-vitro tissue maintenance and analysis.  Drug development for society’s most debilitating and costly diseases - diabetes, obesity, metabolic disorders, vision loss, and cancer - relies on detailed understanding of underlying cellular and bio-molecular mechanisms. 

EnTox’s flagship product, the BaroFuse™, is a versatile analytical platform for live tissue that uncovers cellular mechanisms responsible for metabolic disorders. The ideal tool for studying cellular mechanisms must 1) maintain healthy tissue, 2) characterize function in real-time, and 3) precisely control test compounds and conditions.

EnTox has incorporated these three attributes into the BaroFuse a unique platform - based on pumpless, multi-channel flow technology - that is reproducible and simple to operate.

Published studies highlight maintenance and continuous assessment of diverse human and animal tissue including retina, pancreatic islets, liver, tumor cells and biopsies.  The BaroFuse™ monitors a wide range of functional parameters including metabolites, fuels, cellular signals, and hormones.


Biotechnology

Life Sciences

Therapeutics

EnTox Sciences, Inc.

The Seattle office focuses on biotechnology development and manufacturing, specializing in bioengineering solutions.

People (1)

Jobs (0)

Other offices